Ecosystem
From Discovery to Impact –
Our Innovation Ecosystem Turns Science into Solutions
Evogene’s innovation extends beyond its own walls. Through a global ecosystem of subsidiaries, collaborations, and consortiums, we apply AI-driven computational biology and chemistry to deliver real-world innovation across pharma and agriculture. Each partner in this network leverages Evogene’s scientific expertise to transform discovery into impact, developing sustainable crops, next-generation therapeutics, and novel bio-based products that address real-world needs.
Subsidiaries
Casterra Ag Ltd
Casterra, a wholly owned subsidiary of Evogene, is empowering sustainable agriculture through elite castor seed varieties and development of advanced castor farming systems. Casterra leverages advanced genomic capabilities (licensed from Evogene) with its global breeding network to deliver high-yield castor seeds for the bio-based industries. Building on its elite castor seed varieties, Casterra combines agronomic expertise to develop advanced castor farming systems worldwide, tailored to diverse growing conditions, supporting farmers and industries in achieving sustainable production goals while advancing bio-based solutions.
biomica Ltd
Biomica is a clinical-stage subsidiary focused on the development of microbiome-based therapeutics for human health. Utilizing proprietary computational technology, the company identifies and characterizes microbial candidates to treat various diseases. Biomica’s lead program, BMC128 – a microbiome-based therapeutic designed to enhance anti-tumor immune activity in cancer patients – is currently being developed under an exclusive worldwide licensing agreement with Shanghai Lishan Biopharmaceuticals Co., Ltd. Under this partnership, Lishan Biotech is responsible for the global clinical development, manufacturing, and commercialization of the program, while Biomica remains eligible for development milestone payments and royalties on future commercial sales. Following this transaction, Biomica does not expect to conduct further material operational activities and anticipates distributing the majority of its remaining cash to its shareholders, including Evogene.
Lavie Bio Ltd
Established in 2019, Lavie Bio focused on the development of innovative ag-biological solutions for crop protection. In 2025, the majority of Lavie Bio’s activity was acquired by ICL Group Ltd., a leading global specialty minerals company, ensuring the continued growth and global reach of its innovations. Following this transaction, Lavie Bio does not expect to conduct further material operational activities and anticipates distributing the majority of its remaining cash to its shareholders, including Evogene.
Partners
Finally Foods
Harnessing the power of plants to sustainably produce high-value proteins for the food industry, Finally Foods is at the forefront of molecular farming. Leveraging access to Evogene’s GeneRator AI tech engine, the company modifies plants to express functional proteins such as casein, a key dairy component, using the potato plant as a natural bioreactor. Co-founding the company, a seasoned entrepreneur and Evogene’s former VP of R&D collaborated with The Kitchen FoodTech Hub (TKH) by the Strauss Group.
Crop4Clima Consortium
Evogene has partnered with the Max Planck Institute in the Crop4Clima Consortium funded by the European Union’s Horizon Europe EIC Pathfinder program, to develop resilient crops, including canola and rapeseed, that thrive under arid conditions, are heat resistant, sequester more carbon, and feature other improved traits for the benefit of farmers and the environment.. Empowering farmers with cost-effective, high-performing crops, with improved and predictable yields, it increases food production without compromising nutritional value, supports growth on marginal lands, and contributes to climate change mitigation and global food security.
Together, We Drive Real-World Innovation
Evogene’s ecosystem represents more than partnerships – it’s a shared mission. By connecting science, technology, and purpose, we accelerate innovation that transforms industries and improves lives worldwide.